{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:32:53Z","timestamp":1786361573206,"version":"build-2736575974"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":67,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100007109","name":"Universit\u00e0 degli Studi di Ferrara","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100007109","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Inflammation"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Psoriasis is a chronic, systemic inflammatory disease associated with cardiovascular and metabolic comorbidities. It is driven by a sustained immune response in the skin, orchestrated by keratinocytes and both innate and adaptive immune cells. The initial phase of the pathology remains largely unclear. It likely involves the activation of dendritic cells by stress signals from keratinocytes with the NLRP3 inflammasome potentially acting as a key innate sensor. Here we investigate the effects of the topical administration of the selective NLRP3 inhibitor MCC950, in the imiquimod-induced psoriasis-like inflammation model with the aim to achieve the inhibition of both cutaneous and systemic manifestations. Topical MCC950 effectively suppressed NLRP3 inflammasome activation by preventing pro-caspase-1 cleavage and generation of the active p20 subunit in the skin. Gene expression analysis showed that inhibition of NLRP3 suppressed the expression of psoriasis hallmark genes, including\n                    <jats:italic>Il17<\/jats:italic>\n                    ,\n                    <jats:italic>Tnf<\/jats:italic>\n                    ,\n                    <jats:italic>S100a8\/a9<\/jats:italic>\n                    and\n                    <jats:italic>Il1b<\/jats:italic>\n                    . Furthermore, network analysis identified NLRP3 as a central hub in the psoriasis-associated inflammatory module, supporting the concept that inflammasome inhibition dampens multiple downstream inflammatory pathways. In psoriasis-like condition, MCC950 reduced the skin infiltration of CD3\n                    <jats:sup>+<\/jats:sup>\n                    T cells, CD11b\n                    <jats:sup>+<\/jats:sup>\n                    myeloid and CD11c\n                    <jats:sup>+<\/jats:sup>\n                    dendritic cells. Notably, MCC950 also prevented the systemic effects of psoriasis-like inflammation. Analysis in the spleen shows that it effectively prevented the phenotypic changes induced by psoriasis-like inflammation including the increased frequency of IL-17\u00a0A\n                    <jats:sup>+<\/jats:sup>\n                    T cells. Finally, MCC950 prevented the systemic increase of serum IL-6. These findings highlight that upstream targeting of the NLRP3 inflammasome by MCC950 represents a promising strategy to inhibit both initiation and the systemic spread of psoriasis-like inflammation.\n                  <\/jats:p>","DOI":"10.1007\/s10753-026-02535-1","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T06:54:59Z","timestamp":1780556099000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Skin Application of Inflammasome Inhibitor MCC950 Prevents Psoriasis-like Cutaneous Manifestations and Associated Systemic Inflammation"],"prefix":"10.1007","volume":"49","author":[{"given":"Chiara","family":"Terranova","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Spitilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisia","family":"Camporeale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Nigro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Brugnoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Grassilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Bertagnolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Casciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hasan","family":"Ayaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Tassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Ruzza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Trapella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Granucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Secchiero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Reali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,4]]},"reference":[{"issue":"10281","key":"2535_CR1","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1016\/S0140-6736(20)32549-6","volume":"397","author":"CEM Griffiths","year":"2021","unstructured":"Griffiths, C. E. M., A. W. Armstrong, J. E. Gudjonsson, J. Barker, and Psoriasis. 2021. Lancet 397(10281):1301\u20131315. https:\/\/doi.org\/10.1016\/S0140-6736(20)32549-6","journal-title":"Lancet"},{"key":"2535_CR2","doi-asserted-by":"publisher","unstructured":"Reali, E., and D. Ferrari. 2023. From the Skin to Distant Sites: T Cells in Psoriatic Disease. International Journal Of Molecular Sciences 24(21). https:\/\/doi.org\/10.3390\/ijms242115707","DOI":"10.3390\/ijms242115707"},{"issue":"4","key":"2535_CR3","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1111\/j.1600-0625.2011.01261.x","volume":"20","author":"WH Boehncke","year":"2011","unstructured":"Boehncke, W. H., S. Boehncke, A. M. Tobin, and B. Kirby. 2011. The \u2018psoriatic march\u2019: a concept of how severe psoriasis may drive cardiovascular comorbidity. Experimental Dermatology 20(4):303\u2013307. https:\/\/doi.org\/10.1111\/j.1600-0625.2011.01261.x","journal-title":"Experimental Dermatology"},{"key":"2535_CR4","doi-asserted-by":"publisher","unstructured":"Kamiya, K., M. Kishimoto, J. Sugai, M. Komine, and M. Ohtsuki. 2019. Risk Factors for the Development of Psoriasis. International Journal Of Molecular Sciences 20(18). https:\/\/doi.org\/10.3390\/ijms20184347","DOI":"10.3390\/ijms20184347"},{"issue":"1","key":"2535_CR5","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/s41419-022-04523-3","volume":"13","author":"X Zhou","year":"2022","unstructured":"Zhou, X., Y. Chen, L. Cui, Y. Shi, and C. Guo. 2022. Advances in the pathogenesis of psoriasis: from keratinocyte perspective. Cell Death And Disease 13(1):81. https:\/\/doi.org\/10.1038\/s41419-022-04523-3","journal-title":"Cell Death And Disease"},{"key":"2535_CR6","doi-asserted-by":"publisher","DOI":"10.1007\/s12325-025-03363-9","author":"G Han","year":"2025","unstructured":"Han, G., A. Armstrong, J. G. Krueger, and A. Jacobson. 2025. IL-17\u00a0C as a Driver of Inflammation in Psoriasis. Adv Ther. https:\/\/doi.org\/10.1007\/s12325-025-03363-9","journal-title":"Adv Ther"},{"issue":"8","key":"2535_CR7","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1016\/j.jid.2018.02.030","volume":"138","author":"I Gallais Serezal","year":"2018","unstructured":"Gallais Serezal, I., C. Classon, S. Cheuk, M. Barrientos-Somarribas, E. Wadman, and E. Martini et al. 2018. Resident T Cells in Resolved Psoriasis Steer Tissue Responses that Stratify Clinical Outcome. The Journal Of Investigative Dermatology 138(8):1754\u20131763. https:\/\/doi.org\/10.1016\/j.jid.2018.02.030","journal-title":"The Journal Of Investigative Dermatology"},{"key":"2535_CR8","doi-asserted-by":"publisher","unstructured":"Ferrari, D., F. Casciano, P. Secchiero, and E. Reali. 2021. Purinergic Signaling and Inflammasome Activation in Psoriasis Pathogenesis. International Journal Of Molecular Sciences 22(17). https:\/\/doi.org\/10.3390\/ijms22179449","DOI":"10.3390\/ijms22179449"},{"issue":"6","key":"2535_CR9","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/nri3452","volume":"13","author":"E Latz","year":"2013","unstructured":"Latz, E., T. S. Xiao, and A. Stutz. 2013. Activation and regulation of the inflammasomes. Nature Reviews Immunology 13(6):397\u2013411. https:\/\/doi.org\/10.1038\/nri3452","journal-title":"Nature Reviews Immunology"},{"key":"2535_CR10","doi-asserted-by":"publisher","DOI":"10.1007\/s10753-025-02271-y","author":"A Shi","year":"2025","unstructured":"Shi, A., Y. Shu, K. Hu, S. Sudesh, and Y. Tu. 2025. NLRP3-inflammasome Related Genes as Emerging Biomarkers and Therapeutic Targets in Psoriasis. Inflammation. https:\/\/doi.org\/10.1007\/s10753-025-02271-y","journal-title":"Inflammation"},{"key":"2535_CR11","doi-asserted-by":"publisher","unstructured":"Sharma, M., and E. de Alba. 2021. Structure, Activation and Regulation of NLRP3 and AIM2 Inflammasomes. International Journal Of Molecular Sciences 22(2). https:\/\/doi.org\/10.3390\/ijms22020872","DOI":"10.3390\/ijms22020872"},{"issue":"3","key":"2535_CR12","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1124\/pharmrev.122.000629","volume":"75","author":"Q Ma","year":"2023","unstructured":"Ma, Q. 2023. Pharmacological Inhibition of the NLRP3 Inflammasome: Structure, Molecular Activation, and Inhibitor-NLRP3 Interaction. Pharmacological Reviews 75(3):487\u2013520. https:\/\/doi.org\/10.1124\/pharmrev.122.000629","journal-title":"Pharmacological Reviews"},{"key":"2535_CR13","doi-asserted-by":"publisher","unstructured":"Wang, H., L. Ma, W. Su, Y. Liu, N. Xie, and J. Liu. 2025. NLRP3 inflammasome in health and disease (Review). International Journal Of Molecular Medicine 55(3). https:\/\/doi.org\/10.3892\/ijmm.2025.5489","DOI":"10.3892\/ijmm.2025.5489"},{"issue":"9","key":"2535_CR14","doi-asserted-by":"publisher","first-page":"1453","DOI":"10.1038\/s41590-025-02230-7","volume":"26","author":"ANR Weber","year":"2025","unstructured":"Weber, A. N. R., R. M. McManus, V. Hornung, M. Geyer, J. B. Kuemmerle-Deschner, and E. Latz. 2025. The expanding role of the NLRP3 inflammasome from periodic fevers to therapeutic targets. Nature Immunology 26(9):1453\u20131466. https:\/\/doi.org\/10.1038\/s41590-025-02230-7","journal-title":"Nature Immunology"},{"key":"2535_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-026-01656-9","author":"HJ Shin","year":"2026","unstructured":"Shin, H. J., I. S. Kim, J. K. Kim, and E. K. Jo. 2026. Molecular mechanisms of NLRP3 inflammasome activation. Experimental & Molecular Medicine. https:\/\/doi.org\/10.1038\/s12276-026-01656-9","journal-title":"Experimental & Molecular Medicine"},{"issue":"20","key":"2535_CR16","doi-asserted-by":"publisher","first-page":"3853","DOI":"10.1016\/j.molcel.2025.09.018","volume":"85","author":"JKY Yap","year":"2025","unstructured":"Yap, J. K. Y., K. Duszyc, and K. Schroder. 2025. NLRP1 under pressure: An overview of the NLRP1 inflammasome as a sensor of cellular stress. Molecular Cell 85(20):3853\u20133861. https:\/\/doi.org\/10.1016\/j.molcel.2025.09.018","journal-title":"Molecular Cell"},{"issue":"12","key":"2535_CR17","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1111\/exd.12049","volume":"21","author":"M Carlstr\u00f6m","year":"2012","unstructured":"Carlstr\u00f6m, M., A. K. Ekman, S. Petersson, P. S\u00f6derkvist, and C. Enerb\u00e4ck. 2012. Genetic support for the role of the NLRP3 inflammasome in psoriasis susceptibility. Experimental Dermatology 21(12):932\u2013937. https:\/\/doi.org\/10.1111\/exd.12049","journal-title":"Experimental Dermatology"},{"key":"2535_CR18","doi-asserted-by":"publisher","first-page":"4714836","DOI":"10.1155\/2018\/4714836","volume":"2018","author":"P Yu","year":"2018","unstructured":"Yu, P., S. Hao, H. Zheng, X. Zhao, and Y. Li. 2018. Association of NLRP1 and NLRP3 Polymorphisms with Psoriasis Vulgaris Risk in the Chinese Han Population. Biomed Research International 2018:4714836. https:\/\/doi.org\/10.1155\/2018\/4714836","journal-title":"Biomed Research International"},{"issue":"1","key":"2535_CR19","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1186\/s12865-024-00630-2","volume":"25","author":"FZ Kamel","year":"2024","unstructured":"Kamel, F. Z., H. A. M. Hoseiny, A. A. E. Shahawy, G. Boghdadi, and A. A. E. Shahawy. 2024. NLRP3 (rs10754558) gene polymorphism and tumor necrosis factor alpha as predictors for disease activity and response to methotrexate and adalimumab in psoriasis. Bmc Immunology 25(1):40. https:\/\/doi.org\/10.1186\/s12865-024-00630-2","journal-title":"Bmc Immunology"},{"issue":"3","key":"2535_CR20","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1007\/s00281-019-00733-8","volume":"41","author":"K Yasuda","year":"2019","unstructured":"Yasuda, K., Y. Takeuchi, and K. Hirota. 2019. The pathogenicity of Th17 cells in autoimmune diseases. Seminars In Immunopathology 41(3):283\u2013297. https:\/\/doi.org\/10.1007\/s00281-019-00733-8","journal-title":"Seminars In Immunopathology"},{"key":"2535_CR21","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1146\/annurev-immunol-081022-021207","volume":"41","author":"J Fu","year":"2023","unstructured":"Fu, J., and H. Wu. 2023. Structural Mechanisms of NLRP3 Inflammasome Assembly and Activation. Annual Review Of Immunology 41:301\u2013316. https:\/\/doi.org\/10.1146\/annurev-immunol-081022-021207","journal-title":"Annual Review Of Immunology"},{"key":"2535_CR22","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1146\/annurev-immunol-032713-120225","volume":"32","author":"MA Lowes","year":"2014","unstructured":"Lowes, M. A., M. Suarez-Farinas, and J. G. Krueger. 2014. Immunology of psoriasis. Annual Review Of Immunology 32:227\u2013255. https:\/\/doi.org\/10.1146\/annurev-immunol-032713-120225","journal-title":"Annual Review Of Immunology"},{"issue":"1","key":"2535_CR23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1038\/s41577-024-01075-9","volume":"25","author":"RC Coll","year":"2025","unstructured":"Coll, R. C., and K. Schroder. 2025. Inflammasome components as new therapeutic targets in inflammatory disease. Nature Reviews Immunology 25(1):22\u201341. https:\/\/doi.org\/10.1038\/s41577-024-01075-9","journal-title":"Nature Reviews Immunology"},{"key":"2535_CR24","doi-asserted-by":"publisher","first-page":"175091","DOI":"10.1016\/j.ejphar.2022.175091","volume":"928","author":"H Li","year":"2022","unstructured":"Li, H., Y. Guan, B. Liang, P. Ding, X. Hou, and W. Wei et al. 2022. Therapeutic potential of MCC950, a specific inhibitor of NLRP3 inflammasome. European Journal Of Pharmacology 928:175091. https:\/\/doi.org\/10.1016\/j.ejphar.2022.175091","journal-title":"European Journal Of Pharmacology"},{"key":"2535_CR25","doi-asserted-by":"publisher","first-page":"1624770","DOI":"10.3389\/fimmu.2025.1624770","volume":"16","author":"MV Pinz\u00f3n-Fern\u00e1ndez","year":"2025","unstructured":"Pinz\u00f3n-Fern\u00e1ndez, M. V., J. S. Saavedra-Torres, N. A. L\u00f3pez Garz\u00f3n, J. S. Pachon-Bueno, F. J. Tamayo-Giraldo, and M. C. Rojas Gomez et al. 2025. NLRP3 and beyond: inflammasomes as central cellular hub and emerging therapeutic target in inflammation and disease. Frontiers In Immunology 16:1624770. https:\/\/doi.org\/10.3389\/fimmu.2025.1624770","journal-title":"Frontiers In Immunology"},{"key":"2535_CR26","doi-asserted-by":"publisher","first-page":"108595","DOI":"10.1016\/j.intimp.2022.108595","volume":"106","author":"S Bakhshi","year":"2022","unstructured":"Bakhshi, S., and S. Shamsi. 2022. MCC950 in the treatment of NLRP3-mediated inflammatory diseases: Latest evidence and therapeutic outcomes. International Immunopharmacology 106:108595. https:\/\/doi.org\/10.1016\/j.intimp.2022.108595","journal-title":"International Immunopharmacology"},{"issue":"Pt A","key":"2535_CR27","doi-asserted-by":"publisher","first-page":"110811","DOI":"10.1016\/j.intimp.2023.110811","volume":"124","author":"C Zhang","year":"2023","unstructured":"Zhang, C., B. Tang, X. Zheng, Q. Luo, Y. Bi, and H. Deng et al. 2023. Analysis of the potential pyroptosis mechanism in psoriasis and experimental validation of NLRP3 in vitro and in vivo. International Immunopharmacology 124(Pt A):110811. https:\/\/doi.org\/10.1016\/j.intimp.2023.110811","journal-title":"International Immunopharmacology"},{"issue":"9","key":"2535_CR28","doi-asserted-by":"publisher","first-page":"5836","DOI":"10.4049\/jimmunol.0802999","volume":"182","author":"L van der Fits","year":"2009","unstructured":"van der Fits, L., S. Mourits, J. S. Voerman, M. Kant, L. Boon, and J. D. Laman et al. 2009. Imiquimod-induced psoriasis-like skin inflammation in mice is mediated via the IL-23\/IL-17 axis. The Journal Of Immunology 182(9):5836\u20135845. https:\/\/doi.org\/10.4049\/jimmunol.0802999","journal-title":"The Journal Of Immunology"},{"issue":"7","key":"2535_CR29","doi-asserted-by":"publisher","first-page":"1828","DOI":"10.1038\/jid.2014.28","volume":"134","author":"B Li","year":"2014","unstructured":"Li, B., L. C. Tsoi, W. R. Swindell, J. E. Gudjonsson, T. Tejasvi, and A. Johnston et al. 2014. Transcriptome analysis of psoriasis in a large case-control sample: RNA-seq provides insights into disease mechanisms. The Journal Of Investigative Dermatology 134(7):1828\u20131838. https:\/\/doi.org\/10.1038\/jid.2014.28","journal-title":"The Journal Of Investigative Dermatology"},{"issue":"4","key":"2535_CR30","doi-asserted-by":"publisher","first-page":"e4931","DOI":"10.1371\/journal.pone.0004931","volume":"4","author":"RN Wagner","year":"2009","unstructured":"Wagner, R. N., M. Proell, T. A. Kufer, and R. Schwarzenbacher. 2009. Evaluation of Nod-like receptor (NLR) effector domain interactions. PLoS One 4(4):e4931. https:\/\/doi.org\/10.1371\/journal.pone.0004931","journal-title":"PLoS One"},{"issue":"11","key":"2535_CR31","doi-asserted-by":"publisher","first-page":"6154","DOI":"10.4049\/jimmunol.171.11.6154","volume":"171","author":"C Stehlik","year":"2003","unstructured":"Stehlik, C., S. H. Lee, A. Dorfleutner, A. Stassinopoulos, J. Sagara, and J. C. Reed. 2003. Apoptosis-associated speck-like protein containing a caspase recruitment domain is a regulator of procaspase-1 activation. The Journal Of Immunology 171(11):6154\u20136163. https:\/\/doi.org\/10.4049\/jimmunol.171.11.6154","journal-title":"The Journal Of Immunology"},{"issue":"26","key":"2535_CR32","doi-asserted-by":"publisher","first-page":"8046","DOI":"10.1073\/pnas.1508990112","volume":"112","author":"F Ramirez-Valle","year":"2015","unstructured":"Ramirez-Valle, F., E. E. Gray, and J. G. Cyster. 2015. Inflammation induces dermal Vgamma4\u2009+\u2009gammadeltaT17 memory-like cells that travel to distant skin and accelerate secondary IL-17-driven responses. Proc Natl Acad Sci U S A 112(26):8046\u20138051. https:\/\/doi.org\/10.1073\/pnas.1508990112","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"2535_CR33","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1016\/j.ajpath.2013.04.021","volume":"183","author":"F Bose","year":"2013","unstructured":"Bose, F., L. Petti, M. Diani, C. Moscheni, S. Molteni, and A. Altomare et al. 2013. Inhibition of CCR7\/CCL19 axis in lesional skin is a critical event for clinical remission induced by TNF blockade in patients with psoriasis. American Journal Of Pathology 183(2):413\u2013421. https:\/\/doi.org\/10.1016\/j.ajpath.2013.04.021","journal-title":"American Journal Of Pathology"},{"key":"2535_CR34","doi-asserted-by":"publisher","first-page":"2746","DOI":"10.3389\/fimmu.2018.02746","volume":"9","author":"A Mylonas","year":"2018","unstructured":"Mylonas, A., C. Conrad, and Psoriasis. 2018. Classical vs. Paradoxical. The Yin-Yang of TNF and Type I Interferon. Frontiers In Immunology 9:2746. https:\/\/doi.org\/10.3389\/fimmu.2018.02746","journal-title":"Frontiers In Immunology"},{"issue":"6","key":"2535_CR35","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1038\/jid.2012.33","volume":"132","author":"H Mitsui","year":"2012","unstructured":"Mitsui, H., M. Suarez-Farinas, D. A. Belkin, N. Levenkova, J. Fuentes-Duculan, and I. Coats et al. 2012. Combined use of laser capture microdissection and cDNA microarray analysis identifies locally expressed disease-related genes in focal regions of psoriasis vulgaris skin lesions. The Journal Of Investigative Dermatology 132(6):1615\u20131626. https:\/\/doi.org\/10.1038\/jid.2012.33","journal-title":"The Journal Of Investigative Dermatology"},{"issue":"4","key":"2535_CR36","doi-asserted-by":"publisher","first-page":"e2149702","DOI":"10.1002\/eji.202149702","volume":"53","author":"G Montico","year":"2023","unstructured":"Montico, G., F. Mingozzi, F. Casciano, G. Protti, L. Gornati, and E. Marzola et al. 2023. CCR4(+) CD8(+) T cells clonally expand to differentiated effectors in murine psoriasis and in human psoriatic arthritis. European Journal Of Immunology 53(4):e2149702. https:\/\/doi.org\/10.1002\/eji.202149702","journal-title":"European Journal Of Immunology"},{"issue":"2","key":"2535_CR37","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.immuni.2017.01.009","volume":"46","author":"S Cheuk","year":"2017","unstructured":"Cheuk, S., H. Schlums, I. Gallais Serezal, E. Martini, S. C. Chiang, and N. Marquardt et al. 2017. CD49a Expression Defines Tissue-Resident CD8(+) T Cells Poised for Cytotoxic Function in Human Skin. Immunity 46(2):287\u2013300. https:\/\/doi.org\/10.1016\/j.immuni.2017.01.009","journal-title":"Immunity"},{"issue":"4","key":"2535_CR38","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1016\/j.jaci.2018.08.048","volume":"143","author":"I Gallais Serezal","year":"2019","unstructured":"Gallais Serezal, I., E. Hoffer, B. Ignatov, E. Martini, B. Zitti, and M. Ehrstrom et al. 2019. A skewed pool of resident T cells triggers psoriasis-associated tissue responses in never-lesional skin from patients with psoriasis. The Journal Of Allergy And Clinical Immunology 143(4):1444\u20131454. https:\/\/doi.org\/10.1016\/j.jaci.2018.08.048","journal-title":"The Journal Of Allergy And Clinical Immunology"},{"issue":"9","key":"2535_CR39","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.4049\/jimmunol.2400020","volume":"213","author":"D Sortebech","year":"2024","unstructured":"Sortebech, D., T. Schoenfeldt, A. Duvetorp, R. Agerholm-Nielsen, and L. Eidsmo. 2024. Skin-resident T Cells Contribute to the Dynamic Disease Manifestations of Psoriasis. The Journal Of Immunology 213(9):1267\u20131277. https:\/\/doi.org\/10.4049\/jimmunol.2400020","journal-title":"The Journal Of Immunology"},{"issue":"279","key":"2535_CR40","doi-asserted-by":"publisher","first-page":"279ra39","DOI":"10.1126\/scitranslmed.3010302","volume":"7","author":"R Watanabe","year":"2015","unstructured":"Watanabe, R., A. Gehad, C. Yang, L. L. Scott, J. E. Teague, and C. Schlapbach et al. 2015. Human skin is protected by four functionally and phenotypically discrete populations of resident and recirculating memory T cells. Science Translational Medicine 7(279):279ra39. https:\/\/doi.org\/10.1126\/scitranslmed.3010302","journal-title":"Science Translational Medicine"},{"issue":"3","key":"2535_CR41","doi-asserted-by":"publisher","first-page":"970","DOI":"10.4049\/jimmunol.1202805","volume":"190","author":"SK Bromley","year":"2013","unstructured":"Bromley, S. K., S. Yan, M. Tomura, O. Kanagawa, and A. D. Luster. 2013. Recirculating memory T cells are a unique subset of CD4\u2009+\u2009T cells with a distinct phenotype and migratory pattern. The Journal Of Immunology 190(3):970\u2013976. https:\/\/doi.org\/10.4049\/jimmunol.1202805","journal-title":"The Journal Of Immunology"},{"key":"2535_CR42","doi-asserted-by":"publisher","first-page":"11514","DOI":"10.1038\/ncomms11514","volume":"7","author":"N Collins","year":"2016","unstructured":"Collins, N., X. Jiang, A. Zaid, B. L. Macleod, J. Li, and C. O. Park et al. 2016. Skin CD4(+) memory T cells exhibit combined cluster-mediated retention and equilibration with the circulation. Nature Communications 7:11514. https:\/\/doi.org\/10.1038\/ncomms11514","journal-title":"Nature Communications"},{"issue":"4","key":"2535_CR43","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.immuni.2009.02.007","volume":"30","author":"Y Chung","year":"2009","unstructured":"Chung, Y., S. H. Chang, G. J. Martinez, X. O. Yang, R. Nurieva, and H. S. Kang et al. 2009. Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30(4):576\u2013587. https:\/\/doi.org\/10.1016\/j.immuni.2009.02.007","journal-title":"Immunity"},{"key":"2535_CR44","doi-asserted-by":"publisher","first-page":"1085448","DOI":"10.3389\/fimmu.2023.1085448","volume":"14","author":"Y Zhang","year":"2023","unstructured":"Zhang, Y., X. Xu, H. Cheng, and F. Zhou. 2023. AIM2 and Psoriasis. Frontiers In Immunology 14:1085448. https:\/\/doi.org\/10.3389\/fimmu.2023.1085448","journal-title":"Frontiers In Immunology"},{"key":"2535_CR45","doi-asserted-by":"publisher","unstructured":"Varela Martins, T., B. M. Silva de Melo, J. E. Toller-Kawahisa, G. V. L. da Silva, C. E. Anibal Silva, and I. M. Paiva et al. 2024. The DNA sensor AIM2 mediates psoriasiform inflammation by inducing type 3 immunity. JCI Insight 9(21). https:\/\/doi.org\/10.1172\/jci.insight.171894","DOI":"10.1172\/jci.insight.171894"},{"issue":"4\u20135","key":"2535_CR46","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/s1359-6101(02)00027-8","volume":"13","author":"K Ishihara","year":"2002","unstructured":"Ishihara, K., and T. Hirano. 2002. IL-6 in autoimmune disease and chronic inflammatory proliferative disease. Cytokine & Growth Factor Reviews 13(4\u20135):357\u2013368. https:\/\/doi.org\/10.1016\/s1359-6101(02)00027-8","journal-title":"Cytokine & Growth Factor Reviews"},{"issue":"5","key":"2535_CR47","doi-asserted-by":"publisher","first-page":"345","DOI":"10.1016\/j.it.2017.01.004","volume":"38","author":"S Boettcher","year":"2017","unstructured":"Boettcher, S., and M. G. Manz. 2017. Regulation of Inflammation- and Infection-Driven Hematopoiesis. Trends In Immunology 38(5):345\u2013357. https:\/\/doi.org\/10.1016\/j.it.2017.01.004","journal-title":"Trends In Immunology"},{"issue":"1","key":"2535_CR48","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1186\/s12974-020-01933-y","volume":"17","author":"M Jiang","year":"2020","unstructured":"Jiang, M., R. Li, J. Lyu, X. Li, W. Wang, and Z. Wang et al. 2020. MCC950, a selective NLPR3 inflammasome inhibitor, improves neurologic function and survival after cardiac arrest and resuscitation. J Neuroinflammation 17(1):256. https:\/\/doi.org\/10.1186\/s12974-020-01933-y","journal-title":"J Neuroinflammation"},{"key":"2535_CR49","doi-asserted-by":"publisher","first-page":"1574455","DOI":"10.3389\/fimmu.2025.1574455","volume":"16","author":"F Casciano","year":"2025","unstructured":"Casciano, F., P. Severi, L. Marongiu, A. Caproni, C. Terranova, and A. Spitilli et al. 2025. Highly differentiated T cells link systemic and vascular inflammation in a mouse model of recurrent psoriasis. Frontiers In Immunology 16:1574455. https:\/\/doi.org\/10.3389\/fimmu.2025.1574455","journal-title":"Frontiers In Immunology"},{"issue":"6","key":"2535_CR50","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.clindermatol.2007.08.005","volume":"25","author":"M Murphy","year":"2007","unstructured":"Murphy, M., P. Kerr, and J. M. Grant-Kels. 2007. The histopathologic spectrum of psoriasis. Clinics In Dermatology 25(6):524\u2013528. https:\/\/doi.org\/10.1016\/j.clindermatol.2007.08.005","journal-title":"Clinics In Dermatology"},{"issue":"D1","key":"2535_CR51","doi-asserted-by":"publisher","first-page":"D638","DOI":"10.1093\/nar\/gkac1000","volume":"51","author":"D Szklarczyk","year":"2023","unstructured":"Szklarczyk, D., R. Kirsch, M. Koutrouli, K. Nastou, F. Mehryary, and R. Hachilif et al. 2023. The STRING database in 2023: protein-protein association networks and functional enrichment analyses for any sequenced genome of interest. Nucleic Acids Research 51(D1):D638\u2013D46. https:\/\/doi.org\/10.1093\/nar\/gkac1000","journal-title":"Nucleic Acids Research"}],"container-title":["Inflammation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10753-026-02535-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02535-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10753-026-02535-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T11:03:23Z","timestamp":1786359803000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10753-026-02535-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,4]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["2535"],"URL":"https:\/\/doi.org\/10.1007\/s10753-026-02535-1","relation":{},"ISSN":["1573-2576"],"issn-type":[{"value":"1573-2576","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,4]]},"assertion":[{"value":"14 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 May 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 June 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All procedures involving mice, and their care were performed in conformity with the ethical principles and EU Directive 2010\/63\/EU for animal experiments guidelines. The project was approved by the Italian Ministry of Health (Aut.n.1067\/2023-PR, Aut. n. 171\/2026-PR).","order":1,"name":"Ethics","label":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that no Generative AI was used in the creation of this manuscript.","order":2,"name":"Ethics","label":"Generative AI Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"No clinical trial was conducted as part of this research. Therefore, clinical trial number: not applicable.","order":4,"name":"Ethics","label":"Clinical Trial Number","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"173"}}